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Aspergillus fumigatus molecular typing has become increasingly more important for
detecting outbreaks as well as for local and global epidemiological investigations and
surveillance. Over the years, many different molecular methods have been described
for genotyping this species. Some outstanding approaches are based on microsatellite
markers (STRAf assay, which is the current gold standard), or based on sequencing
data (TRESP typing improved in this work with a new marker and was renamed
TRESPERG). Both methodologies were used to type a collection of 212 A. fumigatus
isolates that included 70 azole resistant strains with diverse resistance mechanisms from
different geographic locations. Our results showed that both methods are totally reliable
for epidemiological investigations showing similar stratification of the A. fumigatus
population. STRAf assay offered higher discriminatory power (D = 0.9993) than the
TRESPERG typing method (D = 0.9972), but the latter does not require specific
equipment or skilled personnel, allowing for a prompt integration into any clinical
microbiology laboratory. Among azole resistant isolates, two groups were differentiated
considering their resistance mechanisms: cyp51A single point mutations (G54, M220, or
G448), and promoter tandem repeat integrations with or without cyp51A modifications
(TR34/L98H, TR46/Y121F/A289T, or TR53). The genotypic differences were assessed to
explore the population structure as well as the genetic relationship between strains and
their azole resistance profile. Genetic cluster analyses suggested that our A. fumigatus
population was formed by 6–7 clusters, depending on the methodology. Also, the azole
susceptible and resistance population showed different structure and organization. The
combination of both methodologies resolved the population structure in a similar way to
what has been described in whole-genome sequencing works.
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INTRODUCTION
Aspergillus fumigatus is a worldwide saprotrophic mold that
produces very large numbers of airborne spores (Latgé, 1999).
It is the primary and most predominant Aspergillus human-
pathogenic species and therefore the most common cause of
aspergillosis (Kontoyiannis et al., 2010; Pappas et al., 2010).
Triazoles are the first line drugs used for treating aspergillosis.
However, the emergence of azole resistance in A. fumigatus is
increasing worldwide, limiting the clinical efficacy of azoles in
both clinical and environmental settings (Verweij et al., 2016).
Up to now, most azole resistance mechanisms in A. fumigatus lay
on overexpression and/or point mutations in cyp51A gene which
encodes a 14-α sterol demethylase involved in the ergosterol
biosynthesis pathway (Lepesheva and Waterman, 2007; Hargrove
et al., 2015).
In this context, two routes of azole resistance acquisition
have been described. The acquisition of resistance in the clinical
setting – the so called medical route – as a consequence of the in-
host drug adaptation of fungus after prolonged azole exposure
(Burgel et al., 2012) involves point mutations in the cyp51A
gene, such as G54 (Diaz-Guerra et al., 2003; Mann et al., 2003),
G138 (Howard et al., 2006), M220 (Mellado et al., 2004; Chen
et al., 2005), and G448 (Bellete et al., 2010; Krishnan Natesan
et al., 2012; Pelaez et al., 2012). Resistance can also been found
in isolates from azole-naive patients (Astvad et al., 2014; Pelaez
et al., 2015), which suggests an acquisition of azole resistant
strains from the environment (Verweij et al., 2007; Snelders
et al., 2008). These isolates harbor specific point mutations in
cyp51A gene together with various size tandem repeat (TR)
integrations in the promoter of the gene, which lead to multiazole
resistance, and is the most common mechanism of resistance
found in environment isolates. The strains most frequently found
have a TR integration of 34-bp in the promoter combined
with L98H substitution in cyp51A gene (Mellado et al., 2007).
Strains with 46-bp promoter integration together with Y121F
and T289A point mutations (Vermeulen et al., 2012; van der
Linden et al., 2013; Pelaez et al., 2015), or only with 53-bp TR
integration and without other cyp51A substitutions (Hodiamont
et al., 2009; Le Pape et al., 2016), have been isolated from the
environmental setting as well as from azole-naive patients. The
environmental route or the medical route of azole resistance
acquisition illustrates the adaptation of isolates to drug selective
pressure. However, the selected azole resistance mechanisms are
very different as well as are their azole susceptibility profiles.
Typing of the isolates could give insight into the dynamics of
azole resistance development within an A. fumigatus population
that includes azole susceptible and resistant isolates with both
types of azole resistance mechanisms.
Currently, the short tandem repeat of A. fumigatus assay
(STRAf ) based on microsatellite analysis is widely accepted
as the reference typing method for this species (de Valk
et al., 2005). It consists of a panel of nine STR markers
amplified by using multicolor multiplex PCR approaches.
However, lack of standardization in the fragment electrophoretic
mobility may complicate result comparisons among laboratories.
This limitation and the technology required have prompted
the development of alternative typing techniques (Balajee
et al., 2008). Recently, a novel genotyping method based on
hypervariable TRs within exons of surface protein coding genes
(TRESP) of three markers has been developed (Garcia-Rubio
et al., 2016). TRESP has a considerable discriminatory power
(D = 0.994), and does not require trained personnel, specific
equipment, or software for analysis. In this study we have
improved TRESP methodology with the inclusion of a fourth
marker to increase its discriminatory power.
The aim of this work was to genotype a large A. fumigatus
collection of azole susceptible and resistant strains with different
resistance mechanisms using both typing methodologies in order
to analyze the potential clustering of isolates according to their
azole resistance mechanism. In addition, both methodologies
were combined to study the improvements in terms of
discriminatory power and population structure.
MATERIALS AND METHODS
Aspergillus fumigatus Strains
A total of 212 A. fumigatus clinical strains isolated from 1997
to 2017 were included in this study (Table 1). Among those,
142 were considered unrelated strains since they were isolated
from individual patients and were azole susceptible strains. Most
of them were from Spain, except for six from Italy, three from
United Kingdom, 2 from Netherlands, and one from France. The
remaining 70 strains were azole resistant A. fumigatus isolates
with different azole resistance mechanisms and geographic
origins.
Fungal DNA was extracted from the isolates as described
previously (Mellado et al., 2001). Isolates were identified to the
species level by PCR amplification and sequencing of ITS region
and β-tubulin gene (Alcazar-Fuoli et al., 2008). The full coding
sequences of cyp51A, including its promoter, were amplified and
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∗On the basis of the azole susceptibility breakpoints, these strains cannot be
considered azole resistant by CLSI nor EUCAST criteria, but they have higher azole
MICs than cyp51A-wild type A. fumigatus strains (Garcia-Rubio et al., 2018).
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sequenced using the PCR conditions described before (Diaz-
Guerra et al., 2003).
TRESPERG Assay
We used TRESP typing markers and PCR conditions already
described (Garcia-Rubio et al., 2016): (i) Afu2g05150 encoding an
MP-2 antigenic galactomannan protein (MP2), (ii) Afu6g14090
encoding hypothetical protein with a CFEM domain (CFEM),
and (iii) Afu3g08990 encoding a cell surface protein A (CSP). The
latter has been the only one extensively used for typing purposes
(Balajee et al., 2007). A fourth target, erg4B gene (Afu1g07140),
which encodes a putative C-24 sterol reductase – named hereafter
ERG marker – was added to improve discriminatory power. ERG
repeat sequences are formed mainly by 12-mer repeats, coding
a particular sequence of amino acids (Supplementary Table S1).
The proposed typing nomenclature for the ERG marker followed
the one described for CSP’s structure (Balajee et al., 2007), in line
with the other TRESP markers (Garcia-Rubio et al., 2016). The
typing method concerning the four markers will from now be
called TRESPERG assay.
Primers used to partially amplify erg4B gene were erg4B_P1
(5′-ATGACTGTCACACGCTCC-3′) and erg4B_P2 (5′-
TAGACGGCACCAATCCAC-3′). Amplicon size was variable,
between 608 and 754 bp, depending on the number of repeats
in each strain. The PCR amplification was performed using the
same equipment as in TRESP typing (Garcia-Rubio et al., 2016)
as follows: 1 cycle of 5 min at 94◦C and then 35 cycles of 30 s at
94◦C, 45 s at 58◦C, and 2 min at 72◦C; and 1 final cycle of 5 min at
72◦C. The PCR products were purified using Illustra Exoprostar
1-step (GE Healthcare Life Science, United Kingdom) and
both strands were sequenced using the same PCR amplification
primers.
Sequences were assembled using the Lasergene software
package (DNAStar, Inc., United States) and aligned using MAFFT
version 7 (Katoh et al., 2002). The final genotype was obtained
after combining the four alleles of each target. In TRESPERG
typing, genotypes were considered identical only when they
showed the same alleles for all four loci.
STRAf Assay
PCR for amplification of the nine STRAf loci in three
multiplexed reactions were performed as previously described
(de Valk et al., 2005). Electropherograms were analyzed using
GeneMapper (version 4.0) software (Thermo Fisher Scientific,
Spain). Genotypes were considered identical when they showed
the same alleles for all nine loci (Balajee et al., 2008; Guinea et al.,
2011).
Discriminatory Power and Genotypic
Diversity Analysis
The discriminatory power was calculated with the Simpson’s
index of diversity (D) using unrelated strains as previously
described (Hunter and Gaston, 1988) therefore only unrelated
azole susceptible strains were used.
For both typing assays, genotypic diversity and clustering
analysis were determined by the Unweighted Pair Group Method
Using Arithmetic Averages (UPGMA) and minimum spanning
trees (MST) were performed using BioNumerics (version 6.0.1)
software (Applied Maths, Belgium).
RESULTS
TRESP Improvement: New TRESPERG
Typing Assay
The nucleotide and amino acid sequence of each repeat type are
described in Supplementary Table S1 and the different ERG alleles
identified among the global A. fumigatus population and the
TR succession forming each allele are shown in Supplementary
Table S2.
New MP2 and CFEM genotypes were found when all strains
were characterized. Three new MP2 variants, designated here
as m1.10, m6.4, and m6.5 were identified (Supplementary Table
S3). In the m6.5 MP2 allele, a new repeat sequence was detected
(GAGACCTCCACTCCTACCGAGACCACTACCACTCCTACC,
named r27). Also, two new CFEM types, c22 and c23, were
described among these isolates and were added to the primary
set (Supplementary Table S4).
TRESPERG revealed a total of 119 different genotypes among
the 142 azole susceptible unrelated A. fumigatus strains. In
summary 20 CSP, 30 MP2, 24 CFEM, and 17 ERG genotypes were
identified. Using these results, the discriminatory power (D) of
the technique was 0.9972 (Table 2). When the 212 strains were
considered, the number of TRESPERG genotypes increased to
156, and the number of genotypes for each marker also increased:
22 CSP, 32 MP2, 25 CFEM, and 18 ERG. In this case, the D
decreased to 0.9933 (Table 2). The MST (Figure 1A) showed
high genotypic variability among the A. fumigatus isolates,
where seven genetic clusters were identified, consistent with the
TRESPERG dendrogram (Supplementary Figure S1).
STRAf Analysis
The same 142 unrelated strains were used for STRAf typing
analysis, obtaining 135 different genotypes. When all the strains
were included, the number of genotypes increased to 195. The D
value of the STRAf assay, calculated using only unrelated strains,
was 0.9993, while it was 0.9992 when all isolates were included
in the analysis (Table 2). STRAf showed higher genotypic
variability than TRESPERG (Figure 1B), but the A. fumigatus
population could be distributed in six clusters instead of seven
(Supplementary Figure S2).
Genotypic Diversity: Typing Azole
Resistance
The set of 70 A. fumigatus azole resistant strains included: (i)
strains only with cyp51A single point mutations (G54, M220, or
G448) and (ii) strains with tandem integrations and/or cyp51A
mutations (TR34/L98H, TR46/Y121F/T289A, or TR53). There
were three azole resistant wild type cyp51A strains that were
included with isolates from the cyp51A single point mutations
group for the analysis. When both typing methods were
considered individually, there were some differences in terms of
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TABLE 2 | Number of different genotypes and Simpson’s index of diversity (D) for both typing methodologies (TRESPERG and STRAf ), a STRAf variant (STRAf without
M3), and the combination of both methods (Combined).
Susceptible unrelated strains Resistant strains Overall
(n = 142) (n = 70) (n = 212)
TR with cyp51A point mutations cyp51A point mutations
(n = 43) (n = 27)
Markers No. GT∗ D No. GT∗ D No. GT∗ D No. GT∗ D
TRESPERG 119 0.9972 27 0.9491 20 0.9715 156 0.9933
STRAf 135 0.9993 41 0.9978 20 0.9744 195 0.9992
STRAf without M3 128 0.9985 34 0.9856 19 0.9630 177 0.9979
Combined 136 0.9994 42 0.9989 24 0.9915 201 0.9995
No. GT∗, number of genotypes.
FIGURE 1 | Minimum spanning tree (MST) showing the genotypic diversity of azole susceptible and resistant Aspergillus fumigatus isolates. (A) TRESPERG MST
and (B) STRAf MST. Each circle shows a unique genotype, and its size the number of strains belonging to the same genotype. Connecting lines between circles
show the similarity between genotypes: solid and bold (shaded in gray) indicate only one marker difference, a solid line indicates differences in two markers, and
dashed lines for differences in three or more markers. The different colors of the circles indicate the cyp51A modifications, grouped in azole susceptible, azole
resistant with TRs (R TRs), and azole resistant with punctual cyp51A mutations (R non-TR).
how the A. fumigatus population was clustered. In TRESPERG
assay, seven clusters were identified as said before (Figure 1A
and Supplementary Figure S1). The azole resistant isolates which
harbored a TR resistant mechanism grouped together in only
one cluster, while azole susceptible isolates were distributed in
five clusters (Figure 1 and Supplementary Figure S1). In the
dendrogram, there were two different clusters with only cyp51A-
WT strains, two more independent clusters: one with cyp51A-
5SNPs (F46Y, M172V, N248T, D255E, and E427K) and another
with cyp51A-3SNPs (F46Y, M172V, and E427K) strains (Garcia-
Rubio et al., 2018), two more clusters with cyp51A-WT strains
and single point mutation strains, and finally a greater cluster
where TR are clustered together along with some cyp51A-WT and
point mutation resistant strains.
However, when the STRAf assay was used, the resistant
strains – independently of their resistance mechanisms –
were widely spread as susceptible isolates (Figure 1B and
Supplementary Figure S2). In the dendrogram, a total of six
genetic clusters were found. TR azole resistant strains were
distributed in three different clusters and azole resistant strains
with cyp51A point mutations were spread in four clusters. With
TRESPERG, cyp51A-3SNPs (F46Y, M172V, and E427K) strains
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were grouped all in one cluster, whereas cyp51A-5SNPs (F46Y,
M172V, N248T, D255E, and E427K) strains were distributed in
two different and distant clusters.
Combined TRESPERG STRAf Analysis
In order to determine how much the D would be improved
combining both genotyping techniques, the nine STRAf markers
were combined with the four TRESPERG ones. The D obtained
using only unrelated strains was 0.9994, while it was 0.9995
when all isolates were included in the analysis (Table 2). The
combination of both typing assays analysis was represented in
a MST (Figure 2) and in a dendrogram (Supplementary Figure
S3), showing all TR strains were grouped in only one cluster as in
individual TRESPERG analysis.
DISCUSSION
Many different molecular methods have been described for
A. fumigatus typing purposes, such as random amplified
polymorphic DNA (RAPD) (Loudon et al., 1993), amplified
fragment length polymorphism analysis (AFLP) (Warris et al.,
2003), restriction fragment length polymorphism analysis (RFLP)
(Neuveglise et al., 1996), microsatellite length polymorphism
(MLP) (Bart-Delabesse et al., 1998), retrotransposon insertion-
site context (RISC) typing (de Ruiter et al., 2007), and multilocus
sequence typing (MLST) (Bain et al., 2007). However, the
discriminatory power values are variable among these techniques
and some of them have a poor inter-laboratory reproducibility.
The current gold standard method is the STRAf assay, based
on microsatellite genotyping, which is able to discriminate an
extensive amount of A. fumigatus unrelated isolates with high
discriminatory power (de Valk et al., 2005). STRAf assay is a
potent typing system and a suitable molecular tool to support
outbreak and epidemiological investigations (Balajee et al., 2008).
Microsatellite data, if properly gathered, are straightforward to
analyze. However, it involves some methodological disadvantages
(de Valk et al., 2007; Klaassen and Osherov, 2007; Klaassen,
2009a), which has encouraged the development of novel typing
techniques using more accessible approaches while keeping a
good discriminatory power. In this context, this work aimed
to test two different typing methods with the same set of
A. fumigatus strains, in order to obtain perfectly comparable
discriminatory power values. As an interesting typing alternative,
TRESPERG methodology has a good reproducibility with a
high discriminatory power (D = 0.9972), although less than the
STRAf assay (D = 0.9993) against the same set of unrelated
A. fumigatus strains. In published guidelines for genetic typing
methodologies, some authors established 0.90 as a suitable
discriminatory power (Hunter and Gaston, 1988), while others
recommended that this value was greater than or equal to
0.95 (van Belkum et al., 2007). Both methods, STRAf and
TRESPERG, beat these discriminatory power values. In previous
works, other authors have determined that D for STRAf assay
was 0.999 (de Valk et al., 2005), 0.984 (Guinea et al., 2011)
or 0.969 (Shen et al., 2018), depending on the set of strains.
TRESP typing has been less used and the discriminatory values
ranged from 0.994 (Garcia-Rubio et al., 2016) to 0.939 (Shen
et al., 2018). In all these works, the number of strains and the
set of isolates varied between studies. Since the discriminatory
power must be calculated using unrelated strains, the specific
set of A. fumigatus population strains used to determine the
D of each technique is essential. In this work, the number of
genotypes among the A. fumigatus unrelated population obtained
by STRAf was higher than the genotypes obtained by TRESPERG
(135 vs. 119, respectively). When the 31 genotypes that were
common for more than one isolate in TRESPERG typing were
considered, STRAf was able to discriminate nineteen of them in
different genotypes. On the contrary, among the 15 genotypes
with more than one isolate in STRAf assay, TRESPERG was able
to discriminate only three of them. In this context, STRAf has a
superior D value and is able to discriminate more genotypes than
TRESPERG.
A. fumigatus has been the subject of many studies showing
that this species is genetically very diverse and have a panmictic
population structure using both microsatellite markers or whole
genome sequence data (Abdolrasouli et al., 2015; Ashu et al.,
2017). Both typing methodologies (TRESPERG and STRAf)
were used to compare the genetic diversity and the clustering
of azole resistant A. fumigatus strains isolated from different
geographical locations (Spain, United Kingdom, Netherlands,
Denmark, and France). Most of the clusters contained isolates
from different origins with both typing methods (Supplementary
Figures S1, S2). Similar results have been described in a recent
broad study which typed a huge number of isolates from
13 countries in four continents using STRAf (Ashu et al.,
2017). In this study, the A. fumigatus population grouped into
eight genetic clusters, with seven of the eight clusters showing
wide geographic distributions. However, there were differences
regarding the clustering of the azole resistant population between
the two methodologies tested in our work. Generally, there
is strong evidence that non-TR strains (azole susceptible and
cyp51A single point mutation resistance strains) have a greater
genetic diversity than TR resistant isolates, since the expansion
of these TR resistant strains at a local level is predominantly
clonal (Chowdhary et al., 2012; Abdolrasouli et al., 2015; Chang
et al., 2016; Ashu et al., 2017; Garcia-Rubio et al., 2017; Wang
et al., 2017). Specifically, cyp51A point mutations are more
commonly isolated from patients undergoing long periods of
azole treatment (Burgel et al., 2012), so it can be expected that
they did not have much more in common unless they came
from sequential isolates of the same patient (Dannaoui et al.,
2001; Mortensen et al., 2011). It is important to highlight that
G54E cyp51A point mutation has also been described in both
clinical and environmental isolates, and were distributed in
different genotypic clusters when the STRAf assay was used to
genotype the isolates (Sharma et al., 2015). In addition, these
isolates were cross-resistant to agricultural fungicides, which
suggests that this resistance mechanism can also be acquired from
the environment and coexist with TR isolates (Sharma et al.,
2015).
Our study supported the idea that non-TR strains have a
greater genetic diversity than TR azole resistant isolates by
the fact that cyp51A point mutated resistant and susceptible
Frontiers in Microbiology | www.frontiersin.org 5 July 2018 | Volume 9 | Article 1626
fmicb-09-01626 July 18, 2018 Time: 16:13 # 6
Garcia-Rubio et al. Genotyping A. fumigatus Azole Resistance
FIGURE 2 | Minimum spanning tree showing the genotypic diversity of azole susceptible and resistant Aspergillus fumigatus isolates combining TRESPERG and
STRAf markers. Each circle shows a unique genotype, and its size the number of strains belonging to the same genotype. Connecting lines between circles show
the similarity between genotypes: solid and bold (shaded in gray) indicate only one marker difference, a solid line indicates differences in two markers, and dashed
lines for differences in three or more markers. The different colors of the circles indicate the cyp51A modifications, grouped in azole susceptible, azole R TR, and
azole resistant with punctual cyp51A mutations (R non-TR).
strains were distributed across most of the clusters using both
typing approaches. Moreover, all TR azole resistant strains
(TR34/L98H, TR46/Y121F/T289A, and TR53) were located in
one specific cluster in TRESPERG typing, which reinforces
the previously suggested idea that TR resistance mechanisms
have developed from a reduced set of clonally related strains
with shorter genetic distances among themselves (Snelders
et al., 2009; Camps et al., 2012). Another work has obtained
similar results to those obtained using TRESPERG, with TR
isolates located all together in one specific cluster while non-
TR were distributed across all the clusters formed (Klaassen
et al., 2012). However, this result was not obtained using STRAf
assay, where TR azole resistant strains were distributed in
three different clusters (Supplementary Figure S2). Similarly,
some authors have described this dispersed structure in the
TR azole resistant A. fumigatus population using STRAf as
genotyping method (Ashu et al., 2017; Chen et al., 2018),
although in some studies this may be due to the lack of
differentiation between azole resistance mechanisms (Ashu et al.,
2017).
The way in which each typing method clustered the isolates
of this A. fumigatus population depends on the genetic markers
used and how they express the genetic relationships among
them. In this context, the results seem to indicate that in this
set of strains, TRESPERG markers clustered TR azole resistant
strains in a better manner than STRAf assay did. Indeed,
many authors have described these strains as genetically more
closely related, as indicated by TRESPERG (Snelders et al., 2009;
Camps et al., 2012; Chowdhary et al., 2012; Abdolrasouli et al.,
2015; Chang et al., 2016; Ashu et al., 2017; Wang et al., 2017).
A possible explanation for the disagreement between TRESPERG
and STRAf could be that microsatellites are extremely high
discriminatory as a consequence of its inherent instability.
Therefore, the interpretation of genotypically different isolates
should be analyzed carefully and this instability should be
taken into account (Klaassen, 2009b). Since STRAf M3 has
been described as the most variable and discriminatory marker
(de Valk et al., 2005), the STRAf assay was also analyzed
excluding this marker. The D of the technique continued to
be very high (Table 2), which means STRAf could be used
for typing purposes even if M3 marker is removed from the
assay. Actually, the STRAf MST without M3 (Supplementary
Figure S4) was more similar to the MST obtained by TRESPERG
(Figure 1A), with all azole resistant TR strains located in only one
cluster.
Moreover, the combined analysis of STRAf and TRESPERG
assays (Table 2) resulted in eight clusters (Supplementary Figure
S3) and all TR strains grouped together (Figure 2). Again, this
supports the hypothesis that they could have developed from a
reduced set of clonally related strains and therefore could have
shorter genetic distances compared to other A. fumigatus strains.
Interestingly, all TR46/Y121F/T289A emerged from only one
branch of the MST (Figure 2).
It is worth pointing out that the TR resistant strains
used in this analysis came from different countries in Europe
and were isolated over a long period of time. Their genetic
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distribution could be consistent with the three possibilities
suggested by other authors: (i) the localized and differential
azole drug exposure between regions leads to the distinctive
clonal expansion of triazole resistant genotypes; (ii) the special
predisposition/likelihood of this cluster to develop triazole
resistance; (iii) TR strains could be more receptive than
those in other clusters in accepting triazole-resistant genes via
mating and recombination (Ashu et al., 2017). Future studies
using methodologies with higher resolution, such as whole-
genome sequencing, will help to unravel the A. fumigatus
population structure, giving insight into the dynamics of
resistance
In summary, both TRESPERG and STRAf assays have
sufficient discriminatory power and both are perfectly reliable
for epidemiological investigations showing comparable typing
results from the A. fumigatus population under analysis. STRAf
offered a higher discriminatory power compared to TRESPERG.
However, the latter is able to better group azole resistant
strains depending on their resistance mechanisms. Also, its
methodological simplicity allows for easy integration into any
clinical microbiology laboratory, fulfilling all the needs of a
suitable typing assay.
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